Daybreak — Ozempic sparked the weight-loss drug trend. Mounjaro is leading it in India

SCOUT· 20%11m·2025-10-09·News Politics

Ozempic sparked the weight-loss drug trend. Mounjaro is leading it in India

Daybreak · 595

Six months after launch, Eli Lilly’s Mounjaro is already India’s second-biggest pharma brand, ahead of antacid Pan and just behind antibiotic Augmentin. Days later, Eli Lilly announced a $1 billion investment and a new Hyderabad hub. The timing is no accident: India has one of the world’s largest obese and diabetic…

Listen now

Buzzmeter · cross-platform

20%

SCOUT

Scout bees are checking it out — divided opinions, the swarm hasn't committed.

Hive Vote · Skep listeners

New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Recent reviews

No reviews yet — be the first.

Ozempic sparked the weight-loss drug trend. Mounjaro is leading it in India

Rate this episode

More from Daybreak

Zepto beat Instamart. It still couldn't beat the market

Optimist wants to reinvent the AC. Daikin and LG don’t need to

Zepto's DRHP underlines the inevitable cost at the heart of quick commerce